News - UF Innovate

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

UF Innovate | Accelerate graduate Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced its lead candidate for treating concussion successfully completed a study that indicates ONP-002 does not cause cardiotoxicity.

UF-Developed Genetic Score Improves Outcomes by Personalizing Leukemia Therapy

Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia, a pediatric cancer for which treatment has gone unchanged for 50 years, a new University of Florida Health-led study shows.

University of Florida’s Innovation Academy Showcases Prototypes Created by the Freshmen Class

In this week’s Tech Tuesday, Bethany Gaffey, our host, introduces us to the leader of UF’s Innovation Academy, who recently directed a Catalyst event to showcase prototypes created by the freshman class.

GatorX Advances to Semi-Final Round of XPRIZE Track B Autonomous Wildfire Challenge

Fire Neural Network (FNN) announced that their team, GatorX, is advancing to the semi-final round of the XPRIZE Track B Autonomous Wildfire Challenge. GatorX is a well-rounded partnership between Fire Neural Network, the University of Florida, NVIDIA, SATLANTIS, SwissDrones, Archer Aviation, SWIR Vision Systems, and N5 Sensors.

UF Health Cancer Center Researcher Showcases a New Vaccine That Can Help Fight Diseases

In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey introduces us to the researcher developing a groundbreaking mRNA vaccine with the potential to fight cancer and infectious diseases.

Space-Focused Accelerator Begins Process for Applicants

The Space-Edge Accelerator, an innovation-focused collaboration between the University of Florida, Blue Origin, Space Foundation, the University of Central Florida, Arizona State University, and Vanderbilt University, is opening applications for its inaugural program.

UF News

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

UF-Developed Genetic Score Improves Outcomes by Personalizing Leukemia Therapy

University of Florida’s Innovation Academy Showcases Prototypes Created by the Freshmen Class

GatorX Advances to Semi-Final Round of XPRIZE Track B Autonomous Wildfire Challenge

UF Health Cancer Center Researcher Showcases a New Vaccine That Can Help Fight Diseases

Space-Focused Accelerator Begins Process for Applicants

Access Pediatric Joins ARPA-H Investor Catalyst Hub to Improve Pediatric Specialty Care

New Video Test for Parkinson’s Uses AI to Track How the Disease Is Progressing

Tech Tuesday: Local Company Aims To Cure Blindness and Other Eye Disorders by Targeting Diseased Cells

Blue Origin Announces Crew for New Shepard’s 26th Mission; UF’s Rob Ferl Will Be on Board